New Technology and Clinical Medicine
Clinical outcomes of bronchial artery embolization in treatment of hemoptysis
Chunwei Xia, Xiaofeng Xu, Yiyan Ding, Ye Zhang
Published 2019-08-15
Cite as Chin J Biomed Eng, 2019, 25(4): 482-485. DOI: 10.3760/cma.j.issn.1674-1927.2019.04.019
Abstract
ObjectiveTo investigate the clinical efficacy and adverse reactions of bronchial artery embolization in the treatment of hemoptysis.
MethodsThe clinical data of 145 patients with hemoptysis were retrospectively analyzed, including 84 with bronchiectasis, 35 with pulmonary tuberculosis, 12 with lung cancer, 9 with pulmonary infection, and 5 with unexplained hemoptysis. Bronchial artery embolization was performed with different embolization agents. The therapeutic efficacy of embolization was evaluated.
ResultsThe total effective rate in the 145 patients with hemoptysis was 93.1% (135/145) , and the recurrence rate was 6.9% (10/145) . There were 15 cases of fever and 10 of chest pain after the operation, and the patients were recovered in 2-3 d after symptomatic treatment.
ConclusionBronchial artery embolization is effective in the treatment of massive or recurrent hemoptysis. According to the etiology and vascular condition, individualized selection of embolization agents may improve the success rate of embolization and reduce complications.
Key words:
Hemoptysis; Bronchial artery embolization; Bronchography; Interventional therapy
Contributor Information
Chunwei Xia
Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, China
Xiaofeng Xu
Yiyan Ding
Ye Zhang